These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1082 related items for PubMed ID: 18583087

  • 1. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
    Braun A, Sämann A, Kubiak T, Zieschang T, Kloos C, Müller UA, Oster P, Wolf G, Schiel R.
    Patient Educ Couns; 2008 Oct; 73(1):50-9. PubMed ID: 18583087
    [Abstract] [Full Text] [Related]

  • 2. Quality of diabetes care, diabetes knowledge and risk of severe hypoglycaemia one and four years after participation in a 5-day structured treatment and teaching programme for intensified insulin therapy.
    Schiel R, Ulbrich S, Müller UA.
    Diabetes Metab; 1998 Dec; 24(6):509-14. PubMed ID: 9932217
    [Abstract] [Full Text] [Related]

  • 3. Blood-glucose self-monitoring in insulin treated type 2 diabetes mellitus a cross-sectional study with an intervention group.
    Schiel R, Müller UA, Rauchfub J, Sprott H, Müller R.
    Diabetes Metab; 1999 Sep; 25(4):334-40. PubMed ID: 10566123
    [Abstract] [Full Text] [Related]

  • 4. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
    Schütt M, Kern W, Krause U, Busch P, Dapp A, Grziwotz R, Mayer I, Rosenbauer J, Wagner C, Zimmermann A, Kerner W, Holl RW, DPV Initiative.
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):384-8. PubMed ID: 16915542
    [Abstract] [Full Text] [Related]

  • 5. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
    Fischer JS, McLaughlin T, Loza L, Beauchamp R, Schwartz S, Kipnes M.
    Curr Med Res Opin; 2004 Nov; 20(11):1703-10. PubMed ID: 15537471
    [Abstract] [Full Text] [Related]

  • 6. Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine.
    Bradley C, Gilbride CJ.
    Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():50-65. PubMed ID: 18577157
    [Abstract] [Full Text] [Related]

  • 7. Quality of life as a key indicator of patient satisfaction and treatment compliance in people with type 2 diabetes mellitus in the IMPROVE study: a multicentre, open label, non-randomised, observational trial.
    Mukherjee AK, Reddy VS, Shah S, Jhingan AK, Ramakrishnan P, Prusty V, Singh NS.
    J Indian Med Assoc; 2009 Jul; 107(7):464-70. PubMed ID: 20112854
    [Abstract] [Full Text] [Related]

  • 8. [Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge].
    Ratzmann KP, Schimke E.
    Med Klin (Munich); 1995 Oct 15; 90(10):557-61. PubMed ID: 7500918
    [Abstract] [Full Text] [Related]

  • 9. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France.
    Vexiau P, Mavros P, Krishnarajah G, Lyu R, Yin D.
    Diabetes Obes Metab; 2008 Jun 15; 10 Suppl 1():16-24. PubMed ID: 18435670
    [Abstract] [Full Text] [Related]

  • 10. Should insulin therapy in type 2 diabetic patients be started on an out- or inpatient basis? Results of a prospective controlled trial using the same treatment and teaching programme in ambulatory care and a university hospital.
    Müller UA, Müller R, Starrach A, Hunger-Dathe W, Schiel R, Jörgens V, Grüsser M.
    Diabetes Metab; 1998 Jun 15; 24(3):251-5. PubMed ID: 9690059
    [Abstract] [Full Text] [Related]

  • 11. The KID study IV: effects of inpatient rehabilitation on the frequency of glucose self-monitoring, quality of further primary care, on time being unable to work and on everyday psychic strain of type I and type II diabetics--a one-year follow-up. Kissingen Diabetes Intervention Study.
    Haupt E, Herrmann R, Benecke-Timp A, Vogel H, Haupt A, Walter C.
    Exp Clin Endocrinol Diabetes; 1997 Jun 15; 105(1):21-31. PubMed ID: 9088891
    [Abstract] [Full Text] [Related]

  • 12. [Initiating insulin therapy in patients with diabetes mellitus type 2: in a transmural setting is at least as effective as in an outpatient setting; a retrospective study with a 4-year follow-up].
    Rosendal H, Vondeling H, de Witte LP, Hutubessy RC, van Beekum WT, Heine RJ.
    Ned Tijdschr Geneeskd; 2002 Jan 26; 146(4):166-71. PubMed ID: 11845567
    [Abstract] [Full Text] [Related]

  • 13. Insulin therapy and quality of life. A review.
    Pouwer F, Hermanns N.
    Diabetes Metab Res Rev; 2009 Sep 26; 25 Suppl 1():S4-S10. PubMed ID: 19662621
    [Abstract] [Full Text] [Related]

  • 14. [Differences between diabetes mellitus type 2 patients switched and not switched over to insulin treatment after specialist consultation].
    Goddijn PP, Meyboom-de Jong B, Feskens EJ, van Ballegooie E, Bilo HJ.
    Ned Tijdschr Geneeskd; 1998 May 02; 142(18):1023-6. PubMed ID: 9623204
    [Abstract] [Full Text] [Related]

  • 15. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H, Kohlmann T, Landgraf W, Holle R, Pirk O, Scholten T.
    Dtsch Med Wochenschr; 2009 Jun 02; 134(23):1207-13. PubMed ID: 19472091
    [Abstract] [Full Text] [Related]

  • 16. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P, IMPROVE Study Group Expert Panel.
    Curr Med Res Opin; 2009 Nov 02; 25(11):2643-54. PubMed ID: 19751116
    [Abstract] [Full Text] [Related]

  • 17. The effect of insulin glargine and nutritional model on metabolic control, quality of life and behavior in children and adolescents with type 1 diabetes mellitus.
    Goksen D, Darcan S, Buyukinan M, Köse T, Erermis S, Coker M.
    Acta Diabetol; 2008 Mar 02; 45(1):47-52. PubMed ID: 17928940
    [Abstract] [Full Text] [Related]

  • 18. Adding insulin glargine versus rosiglitazone: health-related quality-of-life impact in type 2 diabetes.
    Vinik AI, Zhang Q.
    Diabetes Care; 2007 Apr 02; 30(4):795-800. PubMed ID: 17259481
    [Abstract] [Full Text] [Related]

  • 19. Closing the gap between literature and practice: evaluation of a teaching programme (in the absence of a structured treatment) on both type 1 and type 2 diabetes.
    Matteucci E, Giampietro O.
    Diabetes Nutr Metab; 2003 Apr 02; 16(5-6):298-305. PubMed ID: 15000441
    [Abstract] [Full Text] [Related]

  • 20. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections.
    EQuality1 Study Group--Evaluation of QUALITY of Life and Costs in Diabetes Type 1, Nicolucci A, Maione A, Franciosi M, Amoretti R, Busetto E, Capani F, Bruttomesso D, Di Bartolo P, Girelli A, Leonetti F, Morviducci L, Ponzi P, Vitacolonna E.
    Diabet Med; 2008 Feb 02; 25(2):213-20. PubMed ID: 18201210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.